Neuron-specific enolase (NSE) is described as the marker of first choice in the monitoring of small cell bronchial carcinoma, whereas CYFRA 21‑1 is superior to NSE for non-small cell bronchial carcinoma.
There is an additional £15 phlebotomy fee